Lamotrigine Tablet
Product Images NDC 70518-1479

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-1479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2d955155 686d 40cd 898e Df7d760247a5 789 2

Lamotrigine tablets in different strengths and shapes: 25 mg white oval tablets scored with 'U 111', 100 mg white triangular tablets scored with 'U 112', 150 mg white triangular tablets scored with 'U 113', and 200 mg light blue triangular tablets scored with 'U 114'. All tablets are oral dosage forms labeled by REMEDYREPACK INC.*

FDA Label Image

Remedy_label (Remedy Label)

Lamotrigine 200 mg tablet label from RemedyRepack Inc. The label indicates a quantity of 30 tablets and includes the product NDC 70518-1479-00. It is marked Rx only and features a barcode and QR code. The label notes the manufacturer as Unichem, Ghaziabad, India, and provides storage instructions and repackager contact information.*

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01

Chemical structure of Lamotrigine, showing a triazine ring with amino groups and a dichlorophenyl substituent, corresponding to the active ingredient in Lamotrigine 200 mg oral tablets by RemedyRepack Inc.*

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02

A line graph comparing failure probability over weeks between Lamotrigine and placebo groups. The x-axis represents weeks up to 100, and the y-axis represents failure probability percentage up to 100%. Both lines show an increasing trend, with a higher failure probability for the placebo group. Censored data points are marked with plus signs.*

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03

A line graph showing failure probability (%) over weeks for Lamotrigine and placebo groups. The x-axis represents time in weeks up to 80, and the y-axis shows failure probability from 0 to 100%. Two curves depict the failure probabilities for Lamotrigine and placebo, with censoring marks indicated. The placebo curve reaches higher failure probabilities earlier compared to Lamotrigine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.